Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-11
SponsorUniversity of British Columbia
About this trial
The goal of this intervention study is to evaluate the difference in nutrition status markers (weight and muscle mass) when giving dietary protein by continuous or bolus delivery in critically ill children ages 1-11y.
The main questions it aims to answer are:
Primary: Bolus protein delivery will lessen the decline in mid-upper arm circumference (MUAC) z-score by 0.5 standard deviation in critically ill children aged 1-11y after 1wk. Ultrasound will correlate to MUAC.
Secondary: Bolus protein delivery will provide more (grams per day) than when provided continuously, therefore it is more likely to meet the minimum estimated needs.
Participants will have daily nutrition intake data collected, and undergo body composition measures (weight, MUAC and ultrasound of the upper thigh muscle) at day of enrollment, and MUAC/Ultrasound on follow up days 3, 5, 7 and 14 after the intervention started.
Eligibility criteria
Qualifiers
Children admitted to PICU over 1 year of age and younger than 11 years of life
Expected to remain in the pediatric intensive care unit for longer than 72 hours
Receiving standard pediatric formula via NGT/OGT/GT
Disqualifiers
Neuromuscular condition such as muscular dystrophy
Admitted with home prescription for high dose steroids, receives growth hormone or insulin
Enteral nutrition is contraindicated or if nutrition requirements are partially/fully met by parenteral nutrition
Formula delivered into the small bowel (duodenum/jejunum, NJT/GJ)
Trial design
Treatments tested in this trial
- Dietary protein
Treatment groups
96 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov